Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,854
Closed -$862K 93
2025
Q4
$862K Sell
6,854
-9,518
-58% -$1.24M 0.18% 68
2025
Q3
$2.4M Buy
16,372
+805
+5% +$122K 0.5% 49
2025
Q2
$2.43M Buy
15,567
+7,999
+106% +$1.27M 0.57% 50
2025
Q1
$1.25M Sell
7,568
-54
-0.7% -$8.98K 0.34% 70
2024
Q4
$1.24M Buy
7,622
+108
+1% +$19.3K 0.31% 69
2024
Q3
$1.47M Sell
7,514
-141
-2% -$26K 0.39% 63
2024
Q2
$1.33M Sell
7,655
-163
-2% -$27.1K 0.38% 65
2024
Q1
$1.32M Buy
7,818
+1
+0% +$187 0.38% 67
2023
Q4
$1.54M Sell
7,817
-22
-0.3% -$3.9K 0.49% 60
2023
Q3
$1.36M Buy
7,839
+121
+2% +$22K 0.47% 62
2023
Q2
$1.33M Sell
7,718
-136
-2% -$23.5K 0.44% 69
2023
Q1
$1.31M Sell
7,854
-19
-0.2% -$3.11K 0.46% 72
2022
Q4
$1.15M Buy
+7,873
New +$1.17M 0.43% 74

Other funds holding ZTS

Hedeker Wealth's ZTS Position: Q1 2026 in Review

Hedeker Wealth sold out of Zoetis (ZTS) in Q1 2026, closing a stake of 6,854 shares — an estimated $862K sold.

Hedeker Wealth first reported a position in ZTS in Q4 2022 and held it in 13 quarters. The position peaked at $2.43M in Q2 2025. 1,606 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Hedeker Wealth reported no remaining Zoetis position as of Q1 2026 after selling out during the quarter.
  • Hedeker Wealth sold 6,854 Zoetis shares in Q1 2026, an estimated $862K.
  • Hedeker Wealth first reported a position in Zoetis in Q4 2022 and held it in 13 quarters.
  • Hedeker Wealth's Zoetis position peaked at $2.43M in Q2 2025.
  • 1,606 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Hedeker Wealth's 13F filing for Q1 2026, filed 11 May 2026.